Cargando…
Effect of a Product Containing Xyloglucan and Pea Protein on a Murine Model of Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory disease of the skin, characterized by dryness and more or less severe itching. The etiology of AD is complex and has not been fully clarified, involving genetic susceptibility, immunological abnormalities, epidermal barrier dysfunction, and environmen...
Autores principales: | Campolo, Michela, Casili, Giovanna, Paterniti, Irene, Filippone, Alessia, Lanza, Marika, Ardizzone, Alessio, Scuderi, Sarah A, Cuzzocrea, Salvatore, Esposito, Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279434/ https://www.ncbi.nlm.nih.gov/pubmed/32438777 http://dx.doi.org/10.3390/ijms21103596 |
Ejemplares similares
-
Evaluation of the Efficacy of Xyloglucan, Pea Protein and Opuntia ficus-indica Extract in a Preclinical Model of Psoriasis
por: Filippone, Alessia, et al.
Publicado: (2023) -
A Combination of Xyloglucan, Pea Protein and Chia Seed Ameliorates Intestinal Barrier Integrity and Mucosa Functionality in a Rat Model of Constipation-Predominant Irritable Bowel Syndrome
por: Filippone, Alessia, et al.
Publicado: (2022) -
Efficacy of a Product Containing Xyloglucan and Pea Protein on Intestinal Barrier Function in a Partial Restraint Stress Animal Model
por: Scuderi, Sarah Adriana, et al.
Publicado: (2022) -
Evaluating the Protective Properties of a Xyloglucan-Based Nasal Spray in a Mouse Model of Allergic Rhinitis
por: Lanza, Marika, et al.
Publicado: (2021) -
Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation
por: Casili, Giovanna, et al.
Publicado: (2020)